February 27, 2015 – Gaithersburg, MD. Plasmonix, Inc will present a poster entitled “New Microarray Slides Capable of Enhancing Fluorescence” at SelectBio’s Microarray Technology conference in Berlin on March 17 – 18. A copy of that poster will be uploaded
January 2, 2015 – Gaithersburg, MD. Plasmonix announced today that it has moved its laboratories and offices to 9119 Gaither Road in Gaithersburg, Maryland.
October 20, 2014 – Baltimore, MD. Plasmonix Inc. announced today the appointment of its 7-member Scientific Advisory Board. This Board is composed of seasoned and well-respected scientists and bio-entrepreneurs from the Baltimore and Bethesda areas. Their names and short biographies
September 19, 2014 – Baltimore, MD. Plasmonix Inc. announced today the commercial release of its QuantArray substrate for proteomics and multiplex applications. These substrates employ Plasmonix’ proprietary Metal Enhanced Fluorescence (MEF) technology which has been shown to enhance fluorescent signal
(Raleigh, NC) — ImmunoReagents, a manufacturer of high quality polyclonal antibodies and reagents used by researchers, pharmaceutical and biotechnology companies, has established that QuantaWell ELISA plates give superior signal sensitivity over traditional 96-well fluorescent plates. See full report at http://www.prlog.org/12295655.pdf
NIST’s Center for Nanoscale Science & Technology released its Spring/Summer 2013 newsletter, featuring Plasmonix’s enhanced QuantArray microarray substrates. The complete CNST newsletter, including the featured article on Plasmonix can be found at: http://www.nist.gov/cnst/upload/CNST_News_Spring_Summer2013.pdf.
Plasmonix is proud to announce its selection as a Maryland 2013 Incubator Company of the Year. The awards go to Maryland companies that are clients of one of the 21 incubators in the State. The six winners were selected only
Plasmonix was named as a finalist today for the 2013 Investment Company of the Year awards. The full press release can be found at: 2013 ICOY Finalist Release
The Center for Fluorescence Spectroscopy (CFS) at the University of Maryland, Baltimore (http://cfs.umbi.umd.edu/)has been awarded a $100,000 Maryland Industrial Partnership award. The award is to support ongoing collaboration between CFS and Plasmonix to develop and commercialize products utilizing approaches developed
Bethesda, Maryland – The Mid-Atlantic Bio Conference today named Plasmonix as one of the companies that will formally present its business innovations and growth strategies to an audience of more than 850 investors, scientists, advisors and professional service providers from